scholarly journals Urothelial carcinoma in COVID-19: lessons from a pandemic and their impact on clinical practice

2021 ◽  
Author(s):  
Georges Abi Tayeh ◽  
Nour Khalil ◽  
Marwan Alkassis ◽  
Fouad Aoun ◽  
Chady Waked ◽  
...  

The COVID-19 pandemic has modified the management of urothelial carcinoma (UC). Eighteen months after the onset of the pandemic, a scoping narrative review was able to state that radical cystectomy for UC should not be delayed beyond 10 weeks when neoadjuvant chemotherapy (NAC) was administered and 12 weeks when it was not. NAC should be considered when imminent chemotherapy cannot be performed. Early cystectomy should not be delayed when indicated for patients with high-risk non-MIBC. Patients with non-MIBC should still receive their induction doses of intravesical instillations. Diagnostic cystoscopy should not be deferred in symptomatic patients. Surgical management of upper tract urothelial carcinoma (UTUC) allows for a wider deferral interval.

2014 ◽  
pp. 131-152
Author(s):  
Georgios Gakis ◽  
Ashish M. Kamat ◽  
Vitaly Margulis ◽  
Seth P. Lerner ◽  
Arnulf Stenzl

2020 ◽  
Author(s):  
Kenji Zennami ◽  
Makoto Sumitomo ◽  
Kiyoshi Takahara ◽  
Takuhisa Nukaya ◽  
Masashi Takenaka ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document